Safety and efficacy of transepithelial phototherapeutic keratectomy with accelerated corneal collagen cross linking in Keratoconus.

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2018/04/012951

Enrollment

Registered

2018-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: (b) Diagnosed as Keratoconus (b) Steepest keratiometry more than 47D (c) Corneal thinnest point 400 micron or more (d) Age 18 years to 50 years

Exclusion criteria

Exclusion criteria: (a) History or corneal disease (b) Corneal thinnest point less than 400 micron (c) Patient not willing or unable to return for schedule of protocol visits (d) Any associated ocular co-morbidities (e) Age less than 18 years

Design outcomes

Primary

Measure	Time frame
To study the safety and efficacy of transepithelial phototherapeutic keratectomy (t-PTK) with accelerated corneal collagen cross linking (ACXL) in Keratoconus.Timepoint: 12 Months	—

Secondary

Measure	Time frame
Visual outcome, astigmatic changes, changes in corneal clarity will be assessed and intra-operative and post-operative complications shall be observed.Timepoint: 12 Months	—

Countries

India

Contacts

Public ContactDr Vinay S Pillai

Giridhar Eye Institute

vinayspillai@gmail.com8547720217

Outcome results